PAR 5.00% 19.0¢ paradigm biopharmaceuticals limited..

Chart, page-3250

  1. 324 Posts.
    lightbulb Created with Sketch. 37
    Agree. This can fluctuate with only a handful of shares trading
    As most agree, don't sweat the short term plays. The bigger prize both in human relief and shareholder value which is not short term
    I do not agree with forecasting this out to 2030 etc. The chances of obtaining real tangible return is a much shorter timeframe. This will be swallowed up I believe within 2 years
    DYOR
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.